← TrialMatch
HomeTrials

The Development of the Walsh Asthma Self-management Programme and Feasibility of Implement

Asthma is a common medical condition in Ireland. Adult patients tend to have periods when their asthma is stable and periods when it worsens. In order to reduce these periods of worsening asthma, effective ongoing management is required day to day by adults with asthma. Teaching adults how to manage their asthma effect

Condition(s)Asthma, Self-management, Asthma Control
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryAsthma is a common medical condition in Ireland. Adult patients tend to have periods when their asthma is stable and periods when it worsens. In order to reduce these periods of worsening asthma, effective ongoing management is required day to day by adults with asthma. Teaching adults how to manage their asthma effectively, plays a huge role in improving their asthma and having a better overall quality of life. This education on managing asthma has many different parts to it. Most adults will discover they have asthma through their general practitioner (GP) and it will be continued to be checked and managed through their GP or general practice nurse (GPN) in their primary care clinic for the duration of their lives. This research study is taking place to find out if a new education progra
Who can participateInclusion Criteria: * Adults over 18 years old * Adults who meet one of the following criteria: a physician's diagnosis of asthma; coded as asthma (R96) as per the international classification of primary care (ICPC) or international classification of diseases (ICD) code J45 with associated use of asthma medications for 6 months prior to study enrolment. Exclusion Criteria: * Adults under 18 years old * Adults with no diagnosis of asthma * Adults receiving asthma education in a specialist hospital or community setting * Adults unable to give informed consent * Smoking ≥ 10 Pack Year History
Ages18 Years
SexAll
Lead sponsorRoyal College of Surgeons, Ireland
LocationsDublin, D, Ireland
Start date2026-05
NCT IDNCT07609134
Official listinghttps://clinicaltrials.gov/study/NCT07609134

🔍 Search all trials →